Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 5 | 9 |
| List of Tables | 8 | 3 |
| List of Figures | 11 | 3 |
| Introduction | 14 | 1 |
| GlobalData Report Guidance | 14 | 1 |
| Overview of the Pharmaceutical and Medical Device Markets | 15 | 48 |
| Pharmaceutical Market | 15 | 1 |
| Market Overview | 15 | 3 |
| Pharmaceutical Exports and Imports | 18 | 1 |
| Supply Channels | 19 | 1 |
| Market Segments | 20 | 1 |
| Generic Drugs | 20 | 1 |
| Biologics/Biosimilars | 20 | 1 |
| Over-the-Counter Drugs | 21 | 1 |
| Major Disease Areas | 21 | 1 |
| Cancer | 21 | 1 |
| AIDS | 22 | 1 |
| Arthritis | 22 | 1 |
| Cardiovascular Diseases | 23 | 1 |
| Diabetes | 23 | 1 |
| Major Companies | 23 | 1 |
| Tecnoquimicas | 23 | 1 |
| Overview | 23 | 1 |
| Product Portfolio | 24 | 1 |
| R&D | 25 | 1 |
| SWOT Analysis | 25 | 2 |
| Pfizer | 27 | 1 |
| Overview | 27 | 1 |
| Product Portfolio | 28 | 1 |
| R&D | 29 | 2 |
| SWOT Analysis | 31 | 5 |
| Merck &Co. | 36 | 1 |
| Overview | 36 | 2 |
| Product Portfolio | 38 | 2 |
| R&D | 40 | 1 |
| SWOT Analysis | 41 | 5 |
| Roche | 46 | 1 |
| Overview | 46 | 1 |
| Product Portfolio | 47 | 1 |
| R&D | 48 | 1 |
| SWOT Analysis | 49 | 7 |
| Procaps | 56 | 1 |
| Overview | 56 | 1 |
| Product Portfolio | 56 | 1 |
| R&D | 57 | 1 |
| SWOT Analysis | 57 | 2 |
| Medical Device Market | 59 | 1 |
| Market Drivers and Barriers | 60 | 1 |
| Drivers | 60 | 1 |
| Barriers | 61 | 2 |
| Market Access | 63 | 43 |
| Reimbursement and Payer Landscape | 63 | 1 |
| Overview of Healthcare System | 63 | 6 |
| Reimbursement Process | 69 | 1 |
| Overview of Insurance Providers | 70 | 1 |
| Public Insurance | 70 | 1 |
| Private Insurance | 70 | 2 |
| Patient Share in Healthcare Spending | 72 | 1 |
| Price Trends in Healthcare Sector | 73 | 1 |
| Pricing Policies | 74 | 3 |
| Regulatory Landscape | 77 | 1 |
| Overview of Regulatory Agencies | 77 | 2 |
| Market Authorization Procedure for Pharmaceutical Products | 79 | 1 |
| Marketing Authorization Procedure New Chemical Entities | 79 | 4 |
| Drug Registration Process for Generics | 83 | 5 |
| New Medical Device Approval Process | 88 | 2 |
| Licensing Process for Pharmaceutical and Medical Device Manufacturing | 90 | 3 |
| Licensing Process for Pharmaceutical Exports and Imports | 93 | 1 |
| Intellectual Property Rights | 94 | 1 |
| Patent | 94 | 4 |
| Trademarks and Service Marks | 98 | 1 |
| Clinical Trial Regulations | 99 | 1 |
| Pharmaceutical Advertising Regulations | 100 | 2 |
| Pharmacy Regulations | 102 | 2 |
| Labeling and Packaging Regulations | 104 | 2 |
| Country Analysis | 106 | 56 |
| Political Environment | 106 | 1 |
| Political Structure | 106 | 1 |
| Analysis of the Current Political Environment | 107 | 2 |
| Healthcare Policy Initiatives | 109 | 1 |
| Economic Landscape | 110 | 2 |
| Economic Indicators | 112 | 1 |
| Gross Domestic Product | 112 | 1 |
| GDP per Capita | 112 | 1 |
| 9T Annual Change in GDP | 113 | 3 |
| Gross National Income | 116 | 1 |
| Inflation | 117 | 1 |
| Consumer Price Index | 117 | 2 |
| Annual Change in Consumer Price | 119 | 1 |
| Currency Exchange Rate | 120 | 1 |
| Foreign Direct Investment | 121 | 1 |
| Foreign Exchange Reserves | 122 | 1 |
| Trade Balance | 123 | 1 |
| Imports of Goods and Services | 123 | 1 |
| Exports of Goods and Services | 124 | 1 |
| General Government Structural Balance | 125 | 1 |
| General Government Net Debt | 126 | 2 |
| Major Industries | 128 | 2 |
| Demographics | 130 | 1 |
| Population | 130 | 2 |
| Urban Rural Share | 132 | 1 |
| Distribution by Age Groups | 133 | 3 |
| Birth Rate | 136 | 1 |
| Mortality | 137 | 1 |
| Causes of Mortality | 137 | 2 |
| Health Status by Gender and Age | 139 | 4 |
| Gender Ratio | 143 | 1 |
| Life Expectancy | 143 | 2 |
| Education and Literacy | 145 | 1 |
| Employment | 146 | 1 |
| Disease Burden | 147 | 1 |
| Disability-Adjusted Life Years | 148 | 2 |
| Healthcare Infrastructure | 150 | 1 |
| Healthcare Parameters | 150 | 1 |
| Hospital-Bed-to-Population Ratio | 150 | 1 |
| Doctor-to-Population Ratio | 151 | 1 |
| Environmental Health | 152 | 1 |
| Air Pollution | 152 | 2 |
| Healthcare Personnel | 154 | 1 |
| Nurses-to-Population Ratio | 154 | 1 |
| Dentists-to-Population Ratio | 155 | 1 |
| Healthcare Expenditure | 156 | 1 |
| Overview | 156 | 1 |
| Major Components of Healthcare Spending | 157 | 1 |
| Public and Private Sector Share | 158 | 1 |
| Trade Associations | 159 | 1 |
| Colombian Pharmaceutical Industry Association | 159 | 1 |
| Association of Pharmaceutical Laboratories Research | 159 | 1 |
| National Academy of Medicine of Colombia | 159 | 1 |
| Colombian Association of Integrative Medicine Business | 160 | 1 |
| The Colombian Association of Medical Schools | 160 | 1 |
| Trade Fairs | 161 | 1 |
| Opportunities and Challenges | 162 | 3 |
| Opportunities | 162 | 1 |
| Challenges | 162 | 3 |
| Appendix | 165 | 17 |
| Abbreviations | 165 | 3 |
| Bibliography | 168 | 10 |
| Research Methodology | 178 | 2 |
| Coverage | 178 | 1 |
| Secondary Research | 178 | 1 |
| Forecasts | 179 | 1 |
| Expert Panel | 179 | 1 |
| Disclaimer | 180 | 2 |